Investors in Iot

Focusing on ICT ventures with a strong growth potential.Dico is a venture capital firm investing in top SaaS companies, driving growth through strategic initiatives like business development and acquisitions.

i&i Prague is a bio-innovation center partner for biotech innovations and smart money investments.i&i Prague is located in the heart of Europe, specializing in identifying and investing in new inventions in Drug Discovery, Diagnostics, MedTech, and other Life Science fields. They support projects from academic institutions.

Nextech Ventures is a venture capital fund that invests in seed stage companies in the e-commerce, analytics, SaaS, and VR sectors.Nextech Ventures provides essential seed stage capital and a nimble team that makes fast decisions. They offer standard term sheets, international VC exposure, and a founders' network. With experience in e-commerce, retail, analytics, SaaS.

BaseLaunch is the Basel-based incubator and accelerator that helps scientists and entrepreneurs launch exceptional biotech companies. It serves as a growth platform for early-stage ventures developing cutting-edge therapeutics. BaseLaunch helps build companies from inception through to Series A funding, providing financing and supporting all aspects of company creation and growth. It is operationally run and financed by Basel Area Business & Innovation, the investment and innovation promotion agency helping companies, institutions and startups find business success in the Basel area.

We invest in innovative private early- to mid-stage human Life Science companies that address important medical needs with novel technologies or products backed by compelling science and with differentiated advantages over current treatment options. Our focus is on Switzerland and surrounding EU countries Germany, Austria, France, Italy and Benelux. We mostly invest in drug development and, to a lesser degree, in diagnostics and medical technology. The amount we aim to invest over the life time of our portfolio companies is up to CHF 10 million.

Aravis is an independent Swiss on-shore private equity fund manager. With our entrepreneurial experience, we take leading positions in our invested portfolio companies and understand the balance between finance, commercial assets and people. We have expanded our team expertise from biotech, renewable energy and luxury goods to creative and digital space as well as industrial high-tech. Our fifth fund focuses on Swiss growth companies that are commercially established (more than CHF 5m turnover) and in need of capital to expand their product offering and enter new markets.

Beyond Impact VC www.beyondimpact.vc advises in the creation of portfolios that accelerate our transition to a cruelty-free world, with a focus on : Organic crop production and distribution Plant-based meat, fish and leather alternatives Vegan convenience foods «Clean» meat, fish and leather Vegan catering and restaurants Vegan clothing and accessories Vegan lifestyle businesses. Replacements for animal testing Cruelty-free, organic household products, toiletries and cosmetics

LEVERAGE build exceptional internet companies. We invest our own experience, time and capital. We are looking for new ambitious projects,specializing in technology investments with a high return rate. They actively build and invest in companies, offering expertise and support to accelerate business growth.

Incuba Venture makes early-stage investments in companies based in Denmark.INCUBA is a leading company environment supporting innovation and growth in IT/tech, cleantech, and life science through knowledge-based support and networking.

Finovam Gestion is an AMF-approved investment company that specializes in taking minority stakes in innovative SMEs with high growth potential across the Hauts de France, Grand-Est, and Bourgogne Franche Comté regions. We manage €100 million and focus on investing in companies that have developed innovative offerings in sectors such as Information and Communication Technologies, Health, Biotechnologies, Agro-resources, and Ecotechnologies. We have established robust relationships within the entrepreneurship ecosystem, collaborating closely with manufacturers, Competitiveness Clusters, Incubators, Accelerators, Universities, and Research Centers across our targeted sectors. This network enables us to effectively source and nurture the best companies for investment. Our investors (LPs) include prominent entities such as BPI France, leading manufacturers (ADEO, LESAFFRE, TEREOS, TOTAL, etc.), major banks (BNP Paribas, Caisse d'Epargne, Crédit Agricole), and the Hauts-de-France, Grand-Est, and Bourgogne-Franche-Comté regions.

GALIA Gestion supports SMEs, mainly in the South-West of France, in their development capital, transmission, and innovation financing operations. Based in Bordeaux and Toulouse with our team of 9 people, we provide tickets ranging from €1 to €9 million on development capital and LBO operations, and between €0.5 and €1 million in venture capital. Our portfolio is made up of around 50 investments, present in various sectors of activity such as software, biotech, electronics, distribution, agri-food, or personal services.

HS LifeSciences was established in 2008 by seasoned biotech entrepreneurs with many years of experience in managing biotech companies. The lessons learned over the years have been distilled into a new business model centered on the foundation and growth of new life sciences companies without the need for conventional multiple rounds of equity-based financing.